Edwards Lifesciences Securities Litigation
Checked October 14, 2026 against the official notice · Edited by Ferhat Abdullahoglu
This settlement resolves claims that Edwards Lifesciences Corporation and its CEO made false statements about the growth prospects of its TAVR platform. If you purchased Edwards common stock between February 6, 2024, and July 24, 2024, you may be eligible for a payment from a $39,000,000 settlement fund. The amount you receive will depend on the number of valid claims filed and can go up or down.
Who qualifies
- Between February 6, 2024 and July 24, 2024.
- Anywhere in the United States.
- Products: Edwards common stock.
“all persons or entities who purchased or otherwise acquired Edwards common stock during the period from February 6, 2024, through July 24, 2024, inclusive (the “Class Period”), and were damaged thereby.”From the court-approved notice
What you can get
These are the amounts the settlement publishes. Shares of a fund depend on how many people file: what pro rata means.
How to file
- 1. Check that the class description above fits you.
- 2. File on the official claim form by December 2, 2026. It usually takes a few minutes.
Key dates
When settlements pay, and what can delay it.
Is this settlement legit?
Yes. It's a court-approved class action settlement in the United States District Court Central District of California Southern Division (case 8:24-cv-02221-AH-KES), run by Kroll Settlement Administration. The official site is edwardslifesciencessecuritieslitigation.com. You never pay to file a claim. How to check a settlement notice.
Related settlements
ClaimWell summarizes the official notice so it's easier to read. It isn't legal advice; the official settlement site is the authority on who qualifies and what each claim pays.